USE OF IC TAGS IN SHORT-TERM CARCINOGENICITY STUDY ON CB6F1 TGrasH2 MICE

スポンサーリンク

概要

• 論文の詳細を見る

• We studied the effect of IC tags, subcutaneously implanted animal identification tools, on rasH2 mice. A 26-week short-term carcinogenicity study was performed on a total of 299 mice including 75 male and female rasH2 mice each, and 74 male and 75 female non-Tg mice from the same litter as the rasH2 mice divided into a non-IC tag group, the IC-tag group, acetone group, TPA group and MNU group (all of the animals except for those in the non-IC tag group) had IC tags implanted subcutaneously in their backs. The administration methods of the positive control drugs TPA (2.5 μg/kg, 3 times/week, percutaneously) and MNU (75 mg/kg, single intraperitoneal injection) were based on the protocol of the ILSI/HESI international collaborative study. The results showed no differences in the tumorigenic incidence and organs developing tumors between the IC tag and non-IC tag groups in both rasH2 and non-Tg mice. In the positive control MNU group, the tumorigenic incidence and organs developing tumors were the same as the background data and no promotion of carcinogenesis was observed. In all IC tag groups including the TPA group and MNU group, a fibrous capsule was formed around the IC tags subcutaneously, but no inflammatory changes or neoplastic changes were observed. From these findings, it was concluded that the IC tag has no effect on a 26-week carcinogenicity test of rasH2 mice under the conditions of the present study.

• 日本トキシコロジー学会の論文
• 2006-12-15

著者

• Suzuki Shuzou

  Central Institute For Experimental Animals

• Machida Kazuhiko

  Central Institute for Experimental Animals

• Urano Koji

  Central Institute for Experimental Animals

• Usui Toshimi

  Central Institute for Experimental Animals

• Urano Kouji

  Central Institute For Experimental Animals

• Machida Kazuhiko

  The Department Of Pathology Nippon Experimental Medical Research Institute Co. Ltd

• EGUCHI Natsuko

  Central Institute for Experimental Animals

• SAWA Nobuko

  Central Institute for Experimental Animals

• KIKUCHI Koji

  JAC, Inc.

• Kikuchi Kouji

  Jac Inc.

• SUZUKI Syuzo

  Central Institute for Experimental Animals

• FUKASAWA Kazumasa

  CLEA Japan, Inc.

• TAGUCHI Fukushi

  CLEA Japan, Inc.

• Taguchi Fukushi

  Clea Japan Inc.

• Fukasawa Kazumasa

  Clea Japan Inc.

関連論文

• Carcinogenic comparative study on rasH2 mice produced by two breeding facilities
• "C-7 A Rapid Carcinogenicity Test in Transgenic Mice Carrying Human c-Ha-ras Gene.
• EXAMINATION OF PERCUTANEOUS APPLICATION IN A 26-WEEK CARCINOGENICITY TEST IN CB6F1-TG rasH2 MICE
• A rapid carcinogenicity testing system using transgenic mice harboring human prototype c-Ha-ras gene
• Induction of Drug Metabolism-Related Enzymes by Methylcholanthrene and Phenobarbital in Transgenic Mice Carrying Human Prototype c-Ha-ras Gene and Their Wild Type Littermates
• Leukocyte Differential Analysis in Multiple Laboratory Species by a Laser Multi-Angle Polarized Light Scattering Separation Method
• Use of IC tags in short-term carcinogenicity studies on CB6F1-TgrasH2 mice(Carcinogenicity, Proceedings of the 32nd Annual Meeting)
• P8-31 Effect of vehicles for a dermal carcinogenicity testing of CB6F1-TgrasH2 mice(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
• P6-41 Comparative study on the carcinogenicity of phenolphthalein in rasH2 and p53 knockout mice(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
• Influence of the administration route and the vehicle on CB6F1-TgrasH2 mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Background data of human prototype c-Ha-ras transgenic (CB6Fl-TgrasH2) mice (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• Biological characteristics of gene-manipulated mice for carcinogenicity test (CARCINOGENICITY) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
• USE OF IC TAGS IN SHORT-TERM CARCINOGENICITY STUDY ON CB6F1 TGrasH2 MICE
• P-44 Some Consideration to the Significance of Serum Immunogiobulin Levels in the Immunotoxicy Testing(Proceedings of the 27th Annual Meeting)
• 22C-10-5 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (2) Immunotoxicity.
• 21D-03-1 Differences in toxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 or 26 weeks (1) General toxicity.
• Historical control data on reproductive abilities and incidences of spontaneous fetal malformations in Wistar Hannover GALAS rats
• P-46 Differences in immunotoxic changes between CB6F1-Tg-rasH2 mice and their nontransgenic littermates given cyclophosphamide by gavage weekly for 5 weeks.(Proceedings of the 27th Annual Meeting)
• Report 1 : TESTING FOR CARCINOGENICITY OF PHARMACEUTICALS : S1, A ; Conditions which require carcinogenicity studies for pharmaceuticals S1, B ; Use of two rodent species S1, C ; Dose selection for carcinogenicity studies of pharmaceuticals (CA
• Acute neurotoxicity study in rats given a single oral administration of Trimethyltin chloride and Acrylamide.(GENERAL SESSION BY POSTER PRESENTATION)(NERVOUS SYSTEM)
• The analysis of locomotor activity of male and female rats in functional observation buttery (FOB) in neurotoxicity study.(GENERAL SESSION BY POSTER PRESENTATION)(NERVOUS SYSTEM)
• Higher susceptibility of NOG mice to xenotransplanted tumors
• Carcinogenic comparative study on rasH2 mice produced by two breeding facilities

もっと見る 閉じる

スポンサーリンク